THURSDAY, Nov. 20, 2025 (HealthDay News) — Plasma infusions may help breast cancer survivors avoid genital and urinary symptoms while on hormone blockers, a recent study says. As many as 70% of breast cancer survivors suffer from vaginal dryness, itching, burning, frequent UTI and pain during sex while taking estrogen-blockingContinue Reading

THURSDAY, Nov. 6, 2025 (HealthDay News) — Transgender women using estradiol for their transition don’t run an increased risk of heart attack or stroke, a new study says. In fact, their hormone treatment might have a protective effect on the heart and blood vessels compared to cisgender men, researchers reportedContinue Reading

TUESDAY, Oct. 21, 2025 (HealthDay News) — Two widely available diabetes medications appear to safely improve brain health among people with early brain decline. The diabetes drug empagliflozin (Jardiance) and an insulin nasal spray both showed promising effects on memory, brain health and blood flow to the brain, researchers recentlyContinue Reading

THURSDAY, Oct. 9, 2025 (HealthDay News) — Wildfire smoke could be damaging men’s fertility, according to a new study. Key measures of sperm quality appeared to drop among dozens of men participating in fertility treatments, researchers recently reported in the journal Fertility and Sterility. “These results reinforce growing evidence thatContinue Reading

WEDNESDAY, Sept. 17, 2025 (HealthDay News) — Hormone replacement therapy might protect a woman’s brain against Alzheimer’s disease, but only if the timing’s right, researchers say. Women who start hormone therapy within five years of menopause can lower their Alzheimer’s risk by as much as 32%, researchers reported this weekContinue Reading

WEDNESDAY, Aug. 6, 2025 (HealthDay News) — The time children and teens spend video gaming, scrolling through social media or watching TV could be putting their future heart health at risk, a new study says. Each additional hour of screen time is associated with an increase in heart risk factorsContinue Reading

THURSDAY, July 24, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has upgraded a recall of a commonly prescribed thyroid medication due to what it described as “subpotent” active ingredients. The recall of more than 160,000 bottles of levothyroxine sodium, which went into effect June 20, wasContinue Reading